# IGC Pharma, Inc.: Form 10-Q/A for the period ended Jun 30, 2012

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 10-Q/A
- Filed: 2012-08-21
- Accepted by EDGAR: Aug 21, 2012, 13:51 ET
- Period: 2012-06-30
- Accession: 0001185185-12-001906
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518512001906/indiaglobal10qa063012.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518512001906/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-04-01 to 2012-06-30 | $1.3m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2012-04-01 to 2012-06-30 | $937.4k | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2012-04-01 to 2012-06-30 | $440.8k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-04-01 to 2012-06-30 | −$194.1k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2012-04-01 to 2012-06-30 | $10.6k | us-gaap:InterestExpense |
| Income tax | 3 months, 2012-04-01 to 2012-06-30 | −$31.7k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-04-01 to 2012-06-30 | −$528.3k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-04-01 to 2012-06-30 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-04-01 to 2012-06-30 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-04-01 to 2012-06-30 | 39,059,336 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2012-04-01 to 2012-06-30 | −$80.5k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2012-04-01 to 2012-06-30 | $0 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2012-06-30 | $719.4k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-06-30 | $5.2m | us-gaap:AssetsCurrent |
| Total assets | at 2012-06-30 | $24.8m | us-gaap:Assets |
| Current liabilities | at 2012-06-30 | $4.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2012-06-30 | $9.4m | us-gaap:Liabilities |
| Short-term borrowings | at 2012-06-30 | $200.8k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2012-06-30 | $14.5m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518512001906/indiaglobal10qa063012.htm

Filed Aug 21, 2012.
Source: SEC EDGAR, the filing index for accession 0001185185-12-001906. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
